|
| ||||||||||
|
|
|
|
|
|
|
||||
| ||||||||||
|
|
|
|
|
Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov. Type 508 Accommodation and the title of the report in the subject line of e-mail. Compendium of Animal Rabies Control, 1996 National Association of State Public Health Veterinarians, Inc. *The purpose of this Compendium is to provide information on rabies to veterinarians, public health officials, and others concerned with rabies control. These recommendations serve as the basis for animal rabies-control programs throughout the United States and facilitate standardization of procedures among jurisdictions, thereby contributing to an effective national rabies-control program. This document is reviewed annually and revised as necessary. Recommendations on immunization procedures are contained in Part I; all animal rabies vaccines licensed by the United States Department of Agriculture (USDA) and marketed in the United States are listed in Part II; Part III details the principles of rabies control. Part I: Recommendations for Immunization Procedures
All animal rabies vaccines should be restricted to use by, or under the direct supervision of, a veterinarian. B. Vaccine Selection In comprehensive rabies-control programs, only vaccines with a 3-year duration of immunity should be used. This procedure constitutes the most effective method of increasing the proportion of immunized dogs and cats in any population. (See Part II.) C. Route of Inoculation All vaccines must be administered in accordance with the specifications of the product label or package insert. If administered intramuscularly, it must be at one site in the thigh. D. Wildlife Vaccination Parenteral vaccination of captive wildlife is not recommended because the efficacy of rabies vaccines in such animals has not been established and no vaccine is licensed for wildlife. For this reason and because virus-shedding periods are unknown, wild or exotic carnivores and bats should not be kept as pets. Zoos or research institutions may establish vaccination programs that attempt to protect valuable animals, but these programs should not be in lieu of appropriate public health activities that protect humans. The use of licensed oral vaccines for the mass immunization of wildlife should be considered in selected situations, with the approval of the state agency responsible for animal rabies control. E. Accidental Human Exposure to Vaccine Accidental inoculation can occur during administration of animal rabies vaccine. Such exposure to inactivated vaccines constitutes no risk for acquiring rabies. F. Identification of Vaccinated Animals All agencies and veterinarians should adopt the standard tag system. This practice will aid the administration of local, state, national, and international rabies-control procedures. Animal license tags should be distinguishable in shape and color from rabies tags. Anodized aluminum rabies tags should be no less than 0.064 inches in thickness.
Part II: Vaccines Marketed in the United States and NASPHV Recommendations (Table_2) Part III: Rabies Control
The public should be warned not to handle wildlife. Wild mammals (as well as the offspring of wild species crossbred with domestic dogs and cats) that bite or otherwise expose people, pets, or livestock should be considered for euthanasia and rabies examination. A person bitten by any wild mammal should immediately report the incident to a physician who can evaluate the need for antirabies treatment. **
THE NASPHV COMMITTEE: Suzanne Jenkins, VMD, MPH, Chair; Keith Clark, DVM, PhD; John Debbie, MS, DVM; Russell Martin, DVM, MPH; Grayson Miller, Jr., MD; F. T. Satalowich, DVM, MSPH; Faye Sorhage, VMD, MPH. CONSULTANTS TO THE COMMITTEE: James Childs, ScD (Centers for Disease Control and Prevention CDCĄ); David Dreesen, DVM, MVPM; David Hines, PhD (Veterinary Biologics Section, Animal Health Institute); William Ingalls, DVM,MS (AVMA Council on Public Health and Regulatory Veterinary Medicine); Robert Miller, DVM, MPH (Animal and Plant Health Inspection Service, USDA); Charles Rupprecht, VMD, PhD (CDC); R. Keith Sikes, DVM, MPH. ENDORSED BY: American Veterinary Medical Association (AVMA) and the Council of State and Territorial Epidemiologists (CSTE). Address all correspondence to: Suzanne Jenkins, VMD, MPH, Office of Epidemiology, Virginia State Department of Health, P.O. Box 2448, Richmond, VA 23218. ** Centers for Disease Control and Prevention. Rabies Prevention --
United
States, 1991. MMWR 1991;40(No. RR-3)1-19. 1. Rabies Tags ================================================================ Calendar year Color Shape ---------------------------------------------------------------- 1996 Red Heart 1997 Blue Rosette 1998 Orange Oval 1999 Green Bell ================================================================ Return to top. Table_2 Note: To print large tables and graphs users may have to change their printer settings to landscape and use a small font size.
Part II: Vaccines Marketed in the United States and NASPHV * Recommendations
=================================================================================================================
Age at
For use Dosage primary Booster Route of
Product name Produced by Marketed by in (mL) vaccination + recommended inoculation
-----------------------------------------------------------------------------------------------------------------
A) INACTIVATED
-----------------------------------------------------------------------------------------------------------------
TRIMUNE Fort Dodge Fort Dodge Dogs 1 3 mos & Triennially IM &
License No. 112 Cats 1 1 yr later Triennially IM
ANNAMUNE Fort Dodge Fort Dodge Dogs 1 3 mos Annually IM
License No. 112 Cats 1 3 mos Annually IM
DURA-RAB 1 ImmunoMed ImmunoMed, Dogs 1 3 mos Annually IM
License No. 421 Vedco, Inc. Cats 1 3 mos Annually IM
DURA-RAB 3 ImmunoMed ImmunoMed, Dogs 1 3 mos & Triennially IM
License No. 421 Vedco, Inc. Cats 1 1 yr later Triennially IM
RABCINE-3 ImmunoMed Pfizer, Inc. Dogs 1 3 mos & Triennially IM
License No. 421 Cats 1 1 yr later Triennially IM
ENDURALL-P Pfizer, Inc. Pfizer, Inc. Dogs 1 3 mos Annually IM or SQ @
or DEFENSOR 1 License No. 189 Cats 1 3 mos Annually SQ
RABGUARD-TC Pfizer, Inc. Pfizer, Inc. Dogs 1 3 mos & Triennially IM
License No. 189 Cats 1 1 yr later Triennially IM
Sheep 1 3 mos Annually IM
Cattle 1 3 mos Annually IM
Horses 1 3 mos Annually IM
DEFENSOR Pfizer, Inc. Pfizer, Inc. Dogs 1 3 mos & Triennially IM or SQ
or DEFENSOR 3 License No. 189 Cats 1 1 yr later Triennially SQ
Sheep 2 3 mos Annually IM
Cattle 2 3 mos Annually IM
RABDOMUN Pfizer, Inc. Mallinckrodt Dogs 1 3 mos & Triennially IM or SQ
License No. 189 Veterinary, Inc. Cats 1 1 yr later Triennially SQ
Sheep 2 3 mos Annually IM
Cattle 2 3 mos Annually IM
RABDOMUN 1 Pfizer, Inc. Mallinckrodt Dogs 1 3 mos Annually IM or SQ
License No. 189 Veterinary, Inc. Cats 1 3 mos Annually SQ
SENTRYRAB-1 Pfizer, Inc. Synbiotics Corp. Dogs 1 3 mos Annually IM
License No. 225 Cats 1 3 mos Annually IM
RABVAC 1 Solvay Animal Solvay Animal Dogs 1 3 mos Annually IM or SQ
Health, Inc. Health, Inc. Cats 1 3 mos Annually IM or SQ
License No.
195 & 195A
RABVAC 3 Solvay Animal Solvay Animal Dogs 1 3 mos & Triennially IM or SQ
Health, Inc. Health, Inc. Cats 1 1 yr later Triennially IM or SQ
License No. Horses 2 3 mos Annually IM
195 & 195A
PRORAB-1 Intervet, Inc. Intervet, Inc. Dogs 1 3 mos Annually IM or SQ
License No. 286 Cats 1 3 mos Annually IM or SQ
Sheep 2 3 mos Annually IM
RM IMRAB 1 Rhone Merieux, Rhone Merieux, Dogs 1 3 mos Annually IM or SQ
Inc. Inc. Cats 1 3 mos Annually IM or SQ
License No. 298
RM IMRAB Rhone Merieux, Rhone Merieux, Cattle 2 3 mos Annually IM or SQ
BOVINE PLUS Inc. Inc. Horses 2 3 mos Annually IM or SQ
License No. 298 Sheep 2 3 mos & Triennially IM or SQ
1 yr later
RM IMRAB 3 Rhone Merieux, Rhone Merieux, Dogs 1 3 mos & Triennially IM or SQ
Inc. Inc. Cats 1 1 yr later Triennially IM or SQ
License No. 298 Sheep 2 3 mos & Triennially IM or SQ
1 yr later
Cattle 2 3 mos Annually IM or SQ
Horses 2 3 mos Annually IM or SQ
Ferrets 1 3 mos Annually SQ
PRORAB-3F Intervet, Inc. Intervet, Inc. Cats 1 3 mos & Triennially IM or SQ
License No. 286 1 yr later
B) COMBINATION (inactivated rabies)
-----------------------------------------------------------------------------------------------------------------
ECLIPSE 3 Solvay Animal Solvay Animal Cats 1 3 mos Annually IM
KP-R Health, Inc. Health, Inc.
License No.
195 & 195A
ECLIPSE 4 Solvay Animal Solvay Animal Cats 1 3 mos Annually IM
KP-R Health, Inc. Health, Inc.
License No.
195 & 195A
FEL-O-VAX Fort Dodge Fort Dodge Cats 1 3 mos & Triennially IM
PCT-R License No. 112 1 yr later
RM FELINE 4 + Rhone Merieux, Rhone Merieux, Cats 1 3 mos & Triennially SQ
IMRAB License No. 298 Inc. 1 yr later
RM FELINE 3 + Rhone Merieux, Rhone Merieux, Cats 1 3 mos & Triennially SQ
IMRAB License No. 298 Inc. 1 yr later
RM EQUINE Rhone Merieux, Rhone Merieux, Horses 1 3 mos Annually IM
POTOMAVAC+ License No. 298 Inc.
IMRAB
ECLIPSE 3+ Solvay Animal Solvay Animal Cats 1 3 mos Annually IM or SQ
FeLV/R Health, Inc. Health, Inc.
License No.
195 & 195A
ECLIPSE 4+ Solvay Animal Solvay Animal Cats 1 3 mos Annually IM or SQ
FeLV/R Health, Inc. Health, Inc.
License No.
195 & 195A
MYSTIQUE II Bayer Corp. Bayer Corp. Horses 1 3 mos & Annually IM
License No. 52 3-4 wks
later **
-----------------------------------------------------------------------------------------------------------------
* National Association of State Public Health Veterinarians, Inc.
+ >=3 months of age and revaccinated 1 year later.
& Intramuscularly.
@ Subcutaneously.
** >=3 months of age and revaccinated 3-4 weeks later.
=================================================================================================================
Return to top. Disclaimer All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices. **Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.Page converted: 09/19/98 |
|||||||||
This page last reviewed 5/2/01
|